Needham & Company and Cantor Fitzgerald raised price objectives and issued buy ratings for Annexon, with MarketBeat reporting consensus data.
4 reports, 1 independent
Updated Sep 12
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Needham & Company and Cantor Fitzgerald raised price objectives and issued buy ratings for Annexon, with MarketBeat reporting consensus data.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Needham & Company
American independent investment bank and asset management firm
-
Cantor Fitzgerald
American financial services company
-
MarketBeat
American personal finance blog
Related events
- Analyst firms Keefe, Bruyette & Woods and Stephens released research reports raising the price target and rating for HomeTrust Bancshares.
- Raymond James Financial reissued an outperform rating and acquired a new position in Boston Scientific shares.
- Needham & Company cut its target price and set a buy rating for Applied Optoelectronics, while Raymond James Financial reiterated an outperform rating. MarketBeat provided consensus data.
- Avalo Therapeutics received multiple rating changes and analyst coverage from firms including Cantor Fitzgerald, Bank of America, and Weiss Ratings.
- Citigroup reissued a market outperform rating and Needham lifted its target price for Alkami Technology Inc.